Stryker (SYK) Change in Account Payables (2009 - 2026)
Stryker's (SYK) quarterly Change in Account Payables came in at -$198.0 million in Q1 2026, up 35.92% year-on-year from -$145.7 million in Q1 2025, and down 166.22% on a QoQ basis from $299.0 million in Q4 2025.
Stryker (SYK) Change in Account Payables (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Change in Account Payables data on file, last reported at -$198.0 million in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 35.92% year-over-year to -$198.0 million in Q1 2026; TTM through Mar 2026 was $205.0 million, a 46.43% increase from a year earlier, with the FY2025 full-year figure at $94.0 million, down 51.04% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$198.0 million, down from $299.0 million in the prior quarter.
- Over the last five years, Change in Account Payables for SYK reached as high as $395.0 million in Q4 2024 and fell as low as -$309.0 million in Q1 2025.
- Historically, Change in Account Payables has averaged $26.8 million across 5 years, with a median of $40.0 million in 2025.
- Across the five-year window, Change in Account Payables plunged 358.93% in 2024 and surged 3100.0% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $179.0 million in 2022, then grew by 8.94% to $195.0 million in 2023, then surged by 102.56% to $395.0 million in 2024, then decreased by 24.3% to $299.0 million in 2025, then slumped by 166.22% to -$198.0 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$198.0 million in Q1 2026, $299.0 million in Q4 2025, and $64.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 56.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -198.00 Mn |
| Mar 31, 2026 | -198.00 Mn |
| Dec 31, 2025 | 299.00 Mn |
| Dec 31, 2025 | 299.00 Mn |
| Sep 30, 2025 | 64.00 Mn |
| Sep 30, 2025 | 64.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Mar 31, 2025 | -309.00 Mn |
| Mar 31, 2025 | -309.00 Mn |
| Dec 31, 2024 | 395.00 Mn |
| Dec 31, 2024 | 395.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 52.00 Mn |
| Jun 30, 2024 | 52.00 Mn |
| Mar 31, 2024 | -257.00 Mn |
| Mar 31, 2024 | -257.00 Mn |
| Dec 31, 2023 | 195.00 Mn |
| Dec 31, 2023 | 195.00 Mn |